Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-dan Huang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 11, 2013
[Hepatitis E in children]Wei-dan Huang, Hui-rong Pan
Human Gene Therapy|March 3, 2011
Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinomaRui-Cheng Wei, Xin Cao, Jing-Hua Gui, et al.
Molecular Cancer|November 2, 2011
HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategyHai-Neng Xu, Wei-Dan Huang, Ying Cai, et al.
International Journal of Cancer|December 2, 2009
Targeting Gene-ViroTherapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 geneJun Kai Fan, Na Wei, Miao Ding, et al.
Human Vaccines & Immunotherapeutics|June 17, 2020
Immunogenicity of an <i>Escherichia coli</i>-produced bivalent human papillomavirus vaccine under different vaccination intervalsXiao-Juan Yu, Juan Li, Zhi-Jie Lin, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|September 11, 2013
[Hepatitis E in children]Wei-dan Huang, Hui-rong Pan
Human Gene Therapy|March 3, 2011
Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinomaRui-Cheng Wei, Xin Cao, Jing-Hua Gui, et al.
Molecular Cancer|November 2, 2011
HCCS1-armed, quadruple-regulated oncolytic adenovirus specific for liver cancer as a cancer targeting gene-viro-therapy strategyHai-Neng Xu, Wei-Dan Huang, Ying Cai, et al.
International Journal of Cancer|December 2, 2009
Targeting Gene-ViroTherapy for prostate cancer by DD3-driven oncolytic virus-harboring interleukin-24 geneJun Kai Fan, Na Wei, Miao Ding, et al.
Human Vaccines & Immunotherapeutics|June 17, 2020
Immunogenicity of an <i>Escherichia coli</i>-produced bivalent human papillomavirus vaccine under different vaccination intervalsXiao-Juan Yu, Juan Li, Zhi-Jie Lin, et al.
Pageof 1